Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krech

Showing results (361-370 of 470) with videos related to

Pageof 47
Sort By:
BMC Cancer|November 23, 2020
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtypeJenny Krause, Johann von Felden, Christian Casar, et al.
International Journal of Molecular Sciences|November 11, 2022
Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer AgentsAnton S Rudovich, Miroslav Peřina, Anastasiya V Krech, et al.
The American Journal of Tropical Medicine and Hygiene|April 22, 2015
Monitoring the quality of medicines: results from Africa, Asia, and South AmericaMustapha Hajjou, Laura Krech, Christi Lane-Barlow, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2023
Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine DiagnosticsNiklas Abele, Katharina Tiemann, Till Krech, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
p16 upregulation is linked to poor prognosis in ERG negative prostate cancerChristoph Burdelski, Tatsiana Dieckmann, Asmus Heumann, et al.
Journal of Hepatology|November 16, 2020
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expressionStephanie Stein, Lara Henze, Tobias Poch, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Oncotarget|August 22, 2015
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Pageof 47

Showing results (361-370 of 470) with videos related to

Sort By:
Pageof 47
BMC Cancer|November 23, 2020
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtypeJenny Krause, Johann von Felden, Christian Casar, et al.
International Journal of Molecular Sciences|November 11, 2022
Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer AgentsAnton S Rudovich, Miroslav Peřina, Anastasiya V Krech, et al.
The American Journal of Tropical Medicine and Hygiene|April 22, 2015
Monitoring the quality of medicines: results from Africa, Asia, and South AmericaMustapha Hajjou, Laura Krech, Christi Lane-Barlow, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2023
Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine DiagnosticsNiklas Abele, Katharina Tiemann, Till Krech, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
p16 upregulation is linked to poor prognosis in ERG negative prostate cancerChristoph Burdelski, Tatsiana Dieckmann, Asmus Heumann, et al.
Journal of Hepatology|November 16, 2020
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expressionStephanie Stein, Lara Henze, Tobias Poch, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Oncotarget|August 22, 2015
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Pageof 47